New

Biologics Market

2021

Biologics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Monoclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cellular-Based Biologics, Gene-Based Biologics, Other Products); Application (Cancer, Infectious Diseases, Autoimmune Diseases, Other Applications)

| Report Code: TIPRE00002765 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Biologics Market 2028 By Product, Application | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Biologics are drugs in the form of genetically engineered proteins derivative of human genes. The biologics can be composed of proteins, sugars, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. Advanced biotechnology techniques and complex processes are used to manufacture biologics, as they are important for biomedical research.

MARKET SCOPE



The "Global Biologics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the biologics market with detailed market segmentation by product, application, and geography. The report provides key statistics on the market status of the leading biologics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on product, the global biologics market is segmented into monoclonal antibodies, vaccines, recombinant hormones/proteins, cellular-based biologics, gene-based biologics, other products.
  • On the basis of application, the market is segmented into cancer, infectious diseases, autoimmune diseases, other applications.

    ?

MARKET DYNAMICS


Drivers:



  • Rise in the prevalence of chronic diseases
  • Growing demand for innovative therapies
  • Loss of patent exclusivity of the leading biologic drugs

Restraints:



  • Stringent Regulatory Process

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The biologics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the market in these regions.

IMPACT OF COVID-19 ON BIOLOGICS MARKET



There has been a huge demand for biologics during the pandemic, which may drive the market growth. For instance, in May 2020, the National Research Council of Canada and CanSino Biologics collaborated for the clinical development of a COVID-19 vaccine in Canada. Over the past few years, the pharmaceutical industry has been the rise of biologics. As this exciting sector grows, it is having a significant impact on the pharmaceutical industry. Thus, extensive research and development activities taking place on biologics for the treatment of COVID-19 are expected to drive the growth of the biologics market in coming years.
?

MARKET PLAYERS



The report covers key developments in the biologics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from biologics market are anticipated to lucrative growth opportunities in the future with the rising demand for biologics market in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the biologics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co.
  • Novo Nordisk AS
  • Pfizer Inc.
  • Sanofi SA

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biologics Market - By Product
1.3.2 Biologics Market - By Application
1.3.3 Biologics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOLOGICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOLOGICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOLOGICS MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOLOGICS - GLOBAL MARKET OVERVIEW
6.2. BIOLOGICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. BIOLOGICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL ANTIBODIES
7.3.1. Overview
7.3.2. Monoclonal Antibodies Market Forecast and Analysis
7.4. VACCINES
7.4.1. Overview
7.4.2. Vaccines Market Forecast and Analysis
7.5. RECOMBINANT HORMONES/PROTEINS
7.5.1. Overview
7.5.2. Recombinant Hormones/Proteins Market Forecast and Analysis
7.6. CELLULAR-BASED BIOLOGICS
7.6.1. Overview
7.6.2. Cellular-Based Biologics Market Forecast and Analysis
7.7. GENE-BASED BIOLOGICS
7.7.1. Overview
7.7.2. Gene-Based Biologics Market Forecast and Analysis
7.8. OTHER PRODUCTS
7.8.1. Overview
7.8.2. Other Products Market Forecast and Analysis
8. BIOLOGICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER
8.3.1. Overview
8.3.2. Cancer Market Forecast and Analysis
8.4. INFECTIOUS DISEASES
8.4.1. Overview
8.4.2. Infectious Diseases Market Forecast and Analysis
8.5. AUTOIMMUNE DISEASES
8.5.1. Overview
8.5.2. Autoimmune Diseases Market Forecast and Analysis
8.6. OTHER APPLICATIONS
8.6.1. Overview
8.6.2. Other Applications Market Forecast and Analysis
9. BIOLOGICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Biologics Market Overview
9.1.2 North America Biologics Market Forecasts and Analysis
9.1.3 North America Biologics Market Forecasts and Analysis - By Product
9.1.4 North America Biologics Market Forecasts and Analysis - By Application
9.1.5 North America Biologics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Biologics Market
9.1.5.1.1 United States Biologics Market by Product
9.1.5.1.2 United States Biologics Market by Application
9.1.5.2 Canada Biologics Market
9.1.5.2.1 Canada Biologics Market by Product
9.1.5.2.2 Canada Biologics Market by Application
9.1.5.3 Mexico Biologics Market
9.1.5.3.1 Mexico Biologics Market by Product
9.1.5.3.2 Mexico Biologics Market by Application
9.2. EUROPE
9.2.1 Europe Biologics Market Overview
9.2.2 Europe Biologics Market Forecasts and Analysis
9.2.3 Europe Biologics Market Forecasts and Analysis - By Product
9.2.4 Europe Biologics Market Forecasts and Analysis - By Application
9.2.5 Europe Biologics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Biologics Market
9.2.5.1.1 Germany Biologics Market by Product
9.2.5.1.2 Germany Biologics Market by Application
9.2.5.2 France Biologics Market
9.2.5.2.1 France Biologics Market by Product
9.2.5.2.2 France Biologics Market by Application
9.2.5.3 Italy Biologics Market
9.2.5.3.1 Italy Biologics Market by Product
9.2.5.3.2 Italy Biologics Market by Application
9.2.5.4 Spain Biologics Market
9.2.5.4.1 Spain Biologics Market by Product
9.2.5.4.2 Spain Biologics Market by Application
9.2.5.5 United Kingdom Biologics Market
9.2.5.5.1 United Kingdom Biologics Market by Product
9.2.5.5.2 United Kingdom Biologics Market by Application
9.2.5.6 Rest of Europe Biologics Market
9.2.5.6.1 Rest of Europe Biologics Market by Product
9.2.5.6.2 Rest of Europe Biologics Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Biologics Market Overview
9.3.2 Asia-Pacific Biologics Market Forecasts and Analysis
9.3.3 Asia-Pacific Biologics Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Biologics Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Biologics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Biologics Market
9.3.5.1.1 Australia Biologics Market by Product
9.3.5.1.2 Australia Biologics Market by Application
9.3.5.2 China Biologics Market
9.3.5.2.1 China Biologics Market by Product
9.3.5.2.2 China Biologics Market by Application
9.3.5.3 India Biologics Market
9.3.5.3.1 India Biologics Market by Product
9.3.5.3.2 India Biologics Market by Application
9.3.5.4 Japan Biologics Market
9.3.5.4.1 Japan Biologics Market by Product
9.3.5.4.2 Japan Biologics Market by Application
9.3.5.5 South Korea Biologics Market
9.3.5.5.1 South Korea Biologics Market by Product
9.3.5.5.2 South Korea Biologics Market by Application
9.3.5.6 Rest of Asia-Pacific Biologics Market
9.3.5.6.1 Rest of Asia-Pacific Biologics Market by Product
9.3.5.6.2 Rest of Asia-Pacific Biologics Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Biologics Market Overview
9.4.2 Middle East and Africa Biologics Market Forecasts and Analysis
9.4.3 Middle East and Africa Biologics Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Biologics Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Biologics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Biologics Market
9.4.5.1.1 South Africa Biologics Market by Product
9.4.5.1.2 South Africa Biologics Market by Application
9.4.5.2 Saudi Arabia Biologics Market
9.4.5.2.1 Saudi Arabia Biologics Market by Product
9.4.5.2.2 Saudi Arabia Biologics Market by Application
9.4.5.3 U.A.E Biologics Market
9.4.5.3.1 U.A.E Biologics Market by Product
9.4.5.3.2 U.A.E Biologics Market by Application
9.4.5.4 Rest of Middle East and Africa Biologics Market
9.4.5.4.1 Rest of Middle East and Africa Biologics Market by Product
9.4.5.4.2 Rest of Middle East and Africa Biologics Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Biologics Market Overview
9.5.2 South and Central America Biologics Market Forecasts and Analysis
9.5.3 South and Central America Biologics Market Forecasts and Analysis - By Product
9.5.4 South and Central America Biologics Market Forecasts and Analysis - By Application
9.5.5 South and Central America Biologics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Biologics Market
9.5.5.1.1 Brazil Biologics Market by Product
9.5.5.1.2 Brazil Biologics Market by Application
9.5.5.2 Argentina Biologics Market
9.5.5.2.1 Argentina Biologics Market by Product
9.5.5.2.2 Argentina Biologics Market by Application
9.5.5.3 Rest of South and Central America Biologics Market
9.5.5.3.1 Rest of South and Central America Biologics Market by Product
9.5.5.3.2 Rest of South and Central America Biologics Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIOLOGICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BIOLOGICS MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AMGEN INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ELI LILLY AND COMPANY
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. F. HOFFMANN-LA ROCHE AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAXOSMITHKLINE PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JOHNSON AND JOHNSON
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MERCK AND CO.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVO NORDISK AS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SANOFI SA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS

The List of Companies

1. AbbVie Inc.
2. Amgen Inc.
3. Eli Lilly and Company
4. F. Hoffmann-La Roche AG
5. GlaxoSmithKline PLC
6. Johnson & Johnson
7. Merck & Co.
8. Novo Nordisk AS
9. Pfizer Inc.
10. Sanofi SA
11. Bayer AG
12. AstraZeneca PLC
13. Regeneron Pharmaceuticals Inc.
14. Novartis AG
15. Teva Pharmaceutical Industries Ltd
TIPRE00002765
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.